focus -WSS

focus

author：knowledge 2025-09-27 10:04:54 - browse：22855

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Diverse clinical trials: Why aren’t we there yet?

WSS

Hospitals consider fixing cancer drug shortages on their own

What to make of Biden’s latest efforts on cancer research

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Generate Biomedicines machine learning biotech raises $273M

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

focus

focus

hotspot

Alkermes shareholders re

What to make of Biden’s latest efforts on cancer research

In age of alternative facts, a scholarly course on calling out crap

Alabama IVF ruling threatens families facing fatal genetic disease

DIEP, the 'gold standard' of breast reconstruction, is under threat

The Harvard botanist who searched for psychedelics in the Amazon

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

hotspot

Diverse clinical trials: Why aren’t we there yet?

Generate Biomedicines machine learning biotech raises $273M

Ed Silverman on new gene therapies, biosimilars, coffee, and more

New Covid vaccine is recommended for everyone 6 months or older

New documents shed light on MD Anderson Cancer Institute feud

Medicare inequities exacerbate Puerto Rico’s health disparities

hotspot

leisure time

focus

focus